Visit Official Site of Glenmark Pharma at http://www.glenmarkpharma.com/ for latest information and updates. Advertisements
Glenmark Pharma announces Phase IIb study results for Oglemilast in COPD | www.glenmarkpharma.com/
Glenmark Pharmaceuticals SA (Switzerland), a subsidiary of Glenmark Pharmaceuticals India, and Forest Laboratories Inc, have announced top-line results from a Phase IIb dose range finding study of Oglemilast in patients with Chronic Obstructive Pulmonary Disease (COPD).
Visit Official Site of Glenmark Pharma at http://www.glenmarkpharma.com/ for latest information and updates. Advertisements
Visit Official Site of Glenmark Pharma at http://www.glenmarkpharma.com/ for latest information and updates. Advertisements
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment